Newborn screening study taps Revvity for genome sequencing
Revvity to work with Early Check, a groundbreaking research study that provides free voluntary health tests for newborns
Stay updated with breaking news from Element Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revvity to work with Early Check, a groundbreaking research study that provides free voluntary health tests for newborns
/PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, has begun taking orders for AVITI24™ the first instrument...
/PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, announced that Element CEO and Co-founder Molly He, PhD,...
Molly He's Element Biosciences has reduced the cost of sequencing a whole genome to $200.
Streamlined workflows for DNA and RNA sequencing are helping clinicians to deliver prompt, targeted care to people in days — or even hours. Streamlined workflows for DNA and RNA sequencing are helping clinicians to deliver prompt, targeted care to people in days — or even hours.